4//SEC Filing
Shukla Sanjay 4
Accession 0001209191-23-058377
CIK 0001339970other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 6:50 PM ET
Size
6.6 KB
Accession
0001209191-23-058377
Insider Transaction Report
Form 4
aTYR PHARMA INCLIFE
Shukla Sanjay
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-12-12$1.18/sh+12,000$14,136→ 106,173 total - Purchase
Common Stock
2023-12-11$1.17/sh+3,000$3,510→ 94,173 total
Footnotes (1)
- [F1]Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Documents
Issuer
aTYR PHARMA INC
CIK 0001339970
Entity typeother
Related Parties
1- filerCIK 0001671026
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 6:50 PM ET
- Size
- 6.6 KB